Sign Up Today and Learn More About Alume Biosciences Stock
Invest in or calculate the value of your shares in Alume Biosciences or other pre-IPO companies through EquityZen's platform.
Alume Biosciences Stock (ALUB)
Alume Biosciences is a biotechnology company developing nerve-targeted pharmaceuticals for surgical and therapeutic use.
About Alume Biosciences Stock
Founded
2017
Headquarters
San Diego, CA, US
Industries
Software, Artificial Intelligence, Data and Analytics
Alume Biosciences Press Mentions
Stay in the know about the latest news on Alume Biosciences
Alume Biosciences Appoints Rick Gonzalez as Chief Commercial Officer
prnewswire • Sep 13, 2024
Alume Biosciences Secures $13M Series B Round
vcnewsdaily • Jan 11, 2023
Alume Biosciences Management
Leadership team at Alume Biosciences
Board Member
Magda Marquet
Chief Financial Officer
James R. Schmidt
Join now and verify your accreditation status to gain access to:
- Alume Biosciences current valuation
- Alume Biosciences stock price
- Available deals in Alume Biosciences and all other companies
- Deal offering documents
- EquityZen's proprietary data and insights, including
- Cap tables, which include funding history by Share Class and Liquidity Preferences
- Company Highlights
- Business Model
- Risk Factors
How to invest in Alume Biosciences stock?
Accredited investors can buy pre-IPO stock in companies like Alume Biosciences through EquityZen funds. These investments are made available by existing Alume Biosciences shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Alume Biosciences stock?
Shareholders can sell their Alume Biosciences stock through EquityZen's private company marketplace. EquityZen's network includes over 330K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 43K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
